These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38479860)

  • 1. Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation.
    Nakano E; Mukai K; Fukuhara A; Otsuki M; Shimomura I; Ichijo T; Tsuiki M; Wada N; Yoneda T; Takeda Y; Oki K; Yamada T; Ogawa Y; Yabe D; Kakutani M; Sone M; Katabami T; Tanabe A; Naruse M;
    Endocr J; 2024 May; 71(5):489-497. PubMed ID: 38479860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism.
    Murata M; Kitamura T; Tamada D; Mukai K; Kurebayashi S; Yamamoto T; Hashimoto K; Hayashi RD; Kouhara H; Takeiri S; Kajimoto Y; Nakao M; Hamasaki T; Otsuki M; Shimomura I
    J Hypertens; 2017 May; 35(5):1079-1085. PubMed ID: 28129245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of peripheral plasma aldosterone concentration and response to ACTH during simultaneous bilateral adrenal veins sampling to predict the source of aldosterone secretion in primary aldosteronism.
    St-Jean M; Bourdeau I; Therasse É; Lacroix A
    Clin Endocrinol (Oxf); 2020 Mar; 92(3):187-195. PubMed ID: 31867770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of midnight 1 mg dexamethasone suppression test combined with ACTH stimulation test in the diagnosis of primary aldosteronism subtypes].
    Qiu P; Zhang L; Jiang DY; Zang L; Guo QH; Lyu ZH; Mu YM
    Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(24):2242-2248. PubMed ID: 38901981
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Utility of the Adrenocorticotropin Stimulation Test with/without Dexamethasone Suppression for Definitive and Subtype Diagnosis of Primary Aldosteronism.
    Inoue K; Omura M; Sugisawa C; Tsurutani Y; Saito J; Nishikawa T
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High plasma aldosterone concentration is associated with worse 24-h ambulatory blood pressure profile in patients with primary aldosteronism.
    Morita R; Azushima K; Sunohara S; Haze T; Kobayashi R; Kinguchi S; Kanaoka T; Kobayashi K; Toya Y; Wakui H; Tamura K
    Hypertens Res; 2023 Aug; 46(8):1995-2004. PubMed ID: 37253977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral aldosterone suppression and its resolution in adrenal vein sampling of patients with primary aldosteronism: analysis of data from the WAVES-J study.
    Shibayama Y; Wada N; Umakoshi H; Ichijo T; Fujii Y; Kamemura K; Kai T; Sakamoto R; Ogo A; Matsuda Y; Fukuoka T; Tsuiki M; Suzuki T; Naruse M
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):696-702. PubMed ID: 27128234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saline Infusion Test highly associated with the incidence of cardio- and cerebrovascular events in primary aldosteronism.
    Hayashi R; Tamada D; Murata M; Mukai K; Kitamura T; Otsuki M; Shimomura I
    Endocr J; 2017 May; 64(5):507-513. PubMed ID: 28321052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient screening of patients with aldosterone-producing adenoma using the ACTH stimulation test.
    Kita T; Furukoji E; Sakae T; Kitamura K
    Hypertens Res; 2019 Jun; 42(6):801-806. PubMed ID: 30622316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma aldosterone response to ACTH stimulation test for diagnosis of primary aldosteronism: a cross-sectional study.
    Manosroi W; Atthakomol P; Inthaphan P; Hintong S
    BMC Endocr Disord; 2024 Mar; 24(1):37. PubMed ID: 38481234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism.
    Saiki A; Otsuki M; Tamada D; Kitamura T; Shimomura I; Kurihara I; Ichijo T; Takeda Y; Katabami T; Tsuiki M; Wada N; Yanase T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Yoshimoto T; Okamoto R; Takahashi K; Kobayashi H; Tamura K; Kamemura K; Yamamoto K; Izawa S; Kakutani M; Yamada M; Tanabe A; Naruse M
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32275055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left-right differences in adrenal vein sampling for primary aldosteronism.
    Miyoshi A; Wada N; Baba S; Obara S; Takahashi B; Usubuchi H; Terae S
    Endocr J; 2020 Mar; 67(3):327-334. PubMed ID: 31801916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism.
    Takeda Y; Umakoshi H; Takeda Y; Yoneda T; Kurihara I; Katabami T; Ichijo T; Wada N; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Takahashi K; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamto K; Ogo A; Yanase T; Suzuki T; Naruse M;
    J Hypertens; 2019 May; 37(5):1077-1082. PubMed ID: 30601318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New diagnostic procedure for primary aldosteronism: adrenal venous sampling under adrenocorticotropic hormone and angiotensin II receptor blocker--application to a case of bilateral multiple adrenal microadenomas.
    Yamahara K; Itoh H; Yamamoto A; Sasano H; Masatsugu K; Sawada N; Fukunaga Y; Sakaguchi S; Sone M; Yurugi T; Nakao K
    Hypertens Res; 2002 Mar; 25(2):145-52. PubMed ID: 12047027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of Different Doses of ACTH Used in ACTH Stimulation Test to Determine the Subtypes of Primary Aldosteronism].
    Qiu P; Zang L; Zhang L; Lyu Z; Mu Y; Guo Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):210-216. PubMed ID: 38322542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism.
    Jiang Y; Zhang C; Wang W; Su T; Zhou W; Jiang L; Zhu W; Xie J; Ning G
    J Clin Endocrinol Metab; 2015 May; 100(5):1837-44. PubMed ID: 25695882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling for the subtyping of primary aldosteronism: a prospective study.
    Yang F; Wang Y; Zhang Z; Zeng Y; Liu M; Tian Z; Li P
    J Hypertens; 2024 Jun; 42(6):1019-1026. PubMed ID: 38527056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of adrenocorticotropin stimulation test in the diagnosis of an aldosterone-producing adenoma.
    Sonoyama T; Sone M; Miyashita K; Tamura N; Yamahara K; Park K; Oyamada N; Taura D; Inuzuka M; Kojima K; Honda K; Fukunaga Y; Kanamoto N; Miura M; Yasoda A; Arai H; Itoh H; Nakao K
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2771-8. PubMed ID: 21752891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol Co-Secretion and Clinical Usefulness of ACTH Stimulation Test in Primary Aldosteronism: A Systematic Review and Biases in Epidemiological Studies.
    Inoue K; Kitamoto T; Tsurutani Y; Saito J; Omura M; Nishikawa T
    Front Endocrinol (Lausanne); 2021; 12():645488. PubMed ID: 33796078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocorticotropic hormone application lowered aldosterone/cortisol value on dominant side without superior surgical outcomes during adrenal venous sampling.
    Lin L; Chen H; Liu Y; Liu Z; Shen S; Xu H; Huang H; Chen T; Zhou L; Zhu Y
    J Clin Hypertens (Greenwich); 2023 Jun; 25(6):555-561. PubMed ID: 37221961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.